Year archive

LungLife AI, INC — 2024 filings

All 27 regulatory filings released by LungLife AI, INC (LLAI) in 2024, sourced directly from the official regulator.

27 Filings

2024 Period

2024 filings (27)

Filing	Released	Lang
Operational update Regulatory Filings	2024-11-19	English
Block listing Interim Review Regulatory Filings	2024-11-15	English
Directorate Change Board/Management Information	2024-10-25	English
Cancellation & Reissue Share Options, PDMR Notice Director's Dealing	2024-10-22	English
Options Cancellation and Re-issuance Regulatory Filings	2024-10-04	English
LungLB® publication in peer-reviewed journal Regulatory Filings	2024-10-02	English
Data Supporting LungLB to be Presented at the AMP Regulatory Filings	2024-09-02	English
Half-year Report Interim / Quarterly Report H1 2024	2024-08-22	English
LCD coverage for Indeterminate Lung Nodules Regulatory Filings	2024-08-16	English
Notice of Results Report Publication Announcement	2024-08-15	English
Result of AGM Declaration of Voting Results & Voting Rights Announcements	2024-06-05	English
Confirmation of AGM AGM Information	2024-06-03	English
Block Listing Six Monthly Return Regulatory Filings	2024-05-15	English
Holding(s) in Company Major Shareholding Notification	2024-05-02	English
Publication of Annual Report and Notice of AGM Report Publication Announcement	2024-04-25	English
Presentation at NCI's EDRN Meeting Regulatory Filings	2024-04-17	English
Preliminary Audited Results Earnings Release FY 2023	2024-04-04	English
Notice of Results Report Publication Announcement	2024-03-27	English
Holding(s) in Company Major Shareholding Notification	2024-03-26	English
Holding(s) in Company Major Shareholding Notification	2024-03-25	English
Admission of New Shares & PDMR Dealing Director's Dealing	2024-03-22	English
Admission of New Shares & PDMR Dealing Regulatory Filings	2024-03-22	English
Result of Special Meeting Declaration of Voting Results & Voting Rights Announcements	2024-03-21	English
Posting of Circular and Notice of Special Meeting Regulatory Filings	2024-03-06	English
Results of Placing and Subscription Capital/Financing Update	2024-03-05	English
Proposed equity raise of approximately £1.8m Capital/Financing Update	2024-03-04	English
Successful validation study results for LungLB® Regulatory Filings	2024-01-02	English